88IV - PR Newswire Asia's news - Health Care/Hospital

< Previous page

| Title only | Print

Next page >

DarwinHealth Introduces Quantum Cancer Biology: A Cell-State Systems Biology Framework for Precision Oncology New paradigm integrates single-cell transcriptomics, regulatory network inference, and AI to decode—and therapeutically target—the multiple, co-existing cancer cell states that drive resistance in pancreatic ... 2026-08-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays SEATTLE and RICHMOND, BC , Aug. 26, 2026 /PRNewswire/ -- Monod Bio, a Seattle-based AI-enabled protein design company, and SignalChem Biotech Inc., a wholly-owned subsidiary of Sino Biological, Inc. ... 2026-08-26T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
SU Group Wins US$2.4 Million Follow-on Award, Expanding Landmark Smart-Hospital Project to US$13.7 Million Additional Award Broadens the Company's Role in Mission-Critical Healthcare Infrastructure and Strengthens Revenue Visibility ... 2026-08-26T Banking/Financial Service Computer/Electronics Health Care/Hospital High Tech Security
PENTAX Medical and MAGENTIQ EYE Expand Global Partnership to Advance AI-Assisted Colonoscopy Worldwide Expanded agreement combines PENTAX Medical's continued investment in flexible reusable endoscopy with MAGENTIQ's clinically validated AI capabilities, expanding access to AI-assisted colonoscopy across ... 2026-08-26T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
From Strategy to Value: Neutech's 2026 Interim Results Confirm the Growth Logic of Its "Education-Healthcare-Wellness" Ecosystem HONG KONG and DALIAN, China , Aug. 26, 2026 /PRNewswire/ -- On 26 August 2026 , Neutech Group Limited (Stock Code: 9616.HK) released its interim results. For the first half of 2026, the Group firmly ... 2026-08-26T Education Health Care/Hospital Higher Education
Alebund Pharmaceuticals Announces 2026 Interim Results SHANGHAI , Aug. 26, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a renal-focused biopharmaceutical company, today ... 2026-08-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
China's BCI Race Accelerates: Gestala Raises US$84 Million in Six Months SHANGHAI and CHENGDU, China , Aug. 26, 2026 /PRNewswire/ -- Gestala officially launched on January 1, 2026. Six months later, the company had completed two financing rounds totaling RMB 570 million, ... 2026-08-26T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Caliway's CBL-514 Combination Therapy Cleared by U.S. FDA for Phase 2 Trial; Pivotal Phase 3 Trial SUPREME-01 Initiates Enrollment FDA IND Clearance for CBL-0201WR —Caliway has cleared its Investigational New Drug application for CBL-0201WR, a Phase 2 trial evaluating CBL-514 in combination with tirzepatide. U.S. IRB Approval ... 2026-08-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
HaemaLogiX Announces Major Milestone with First Patient Successfully Dosed with KMCAR™ T-Cell KEY POINTS ... 2026-08-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
MINISH USA Highlights a Tooth-Preserving Approach Amid Growing Conversations Around Cosmetic Dentistry MINISH USA highlights a restorative approach centered on preserving natural tooth structure. ... 2026-08-26T Health Care/Hospital Household/Consumer/Cosmetics

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved